A method is described for the estimation, in plasma, of glycosylated albumin, using the commercially available affinity chromatographic material Glycogel B (immobilised m-aminophenylboronic acid on an agarose support) to separate the glycosylated and non-glycosylated albumin, followed by the analysis of albumin concentration using rocket immunoelectrophoresis.
A method is described for the estimation, in plasma, of glycosylated albumin, using the commercially available affinity chromatographic material Glycogel B (immobilised m-aminophenylboronic acid on an agarose support) to separate the glycosylated and non-glycosylated albumin, followed by the analysis of albumin concentration using rocket immunoelectrophoresis.
Glycosylated albumin and glycosylated haemoglobin showed good correlation (r=0·91) when both are estimated by affinity chromatography. The glycosylated albumin method displays good within-batch (2·8--4·4% CV) and between-batch (2,9-5,4% CV) precision, and the method is not affected by haemolysis. Using this method a reference range of 2·0-5·4% was found for glycosylated albumin. Levels of glycosylated albumin in diabetics (1O·06±3·23%) were found to be significantly higher (P<O·OOI) than those in non-diabetics (3·72±0·85%).
It was found that loading more than 3 mg of albumin on to a 1 mL affinity column must be avoided, as this appears to overload the column.
It has been established that glycosylated haemoglobin provides an assessment of longterm carbohydrate control in diabetics. I Interest in this glycosylated protein began with the observation by Rahabar/ that diabetic patients had elevated levels of 'fast-moving' haemoglobin (Hb.Aj ) when analysed by electrophoresis. Subsequent work in several laboratories led to the identification of HhAj, as glycosylated haemoglobirrt" with the Amadori product of glucose attached to the aminoterminal valine of the~-chain.
Non-enzymic glycosylation of plasma proteins has been observed by a number of investigators. Incubation of human serum with radio-labelled glucose results in the incorporation of the label into each of the major molecular weight classes of serum protein." Most attention has been given to the glycosylation of serum alburnin.v" which has a shorter half-life than haemoglobin, and several authors have proposed that the level of glycosylated albumin would provide a better indicator of short-term glucose control. [7] [8] [9] [10] Mallia et al. II synthesised a gel consisting of m-aminophenylboronic acid which selectively Correspondence: W G John.
bound diols, and showed that it could be used to separate haemoglobin which had glucose attached to it. The separation of glycosylated haemoglobin by this affinity material has been extensively investigated.P?" and the method was found to be inexpensive, precise and to correlate well with other methods available for glycosylated haemoglobin estimation. 14 In this paper we have extended this affinity method to the estimation, in plasma, of glycosylated albumin.
Materials and methods

SAMPLE COLLECTION
Samples were collected by venepuncture from non-diabetic and diabetic individuals, and added to tubes containing fluoride oxalate. These samples were stored at 4°C until analysed.
SAMPLE PREPARATION
Plasma was separated by centrifugation at 3000 rpm for 5 min. For glycosylated albumin estimation, 100 ul, plasma was taken and added to 1·5 mL water. For glycosylated haemoglobin estimation, 100 ul. of the remaining packed red cells were taken and haemolysed in 2 mL water by vortex mixing for 10 s.
AFFINITY CHROMATOGRAPHY
Glycogel B (Pierce and Warriner, Chester, Cheshire, UK) is supplied as a 50% aqueous slurry. Two millilitres of this slurry (1 mL gel) were added to a mini-column (Pierce and Warriner) and allowed to settle. The columns were equilibrated using 10 mL wash buffer (250 mmol/L ammonium acetate, 50 mmol/L magnesium chloride and 3 mmoVL sodium azide; pH adjusted to 8, 8) . A 100 ul, aliquot of the diluted plasma was added to the top of the column and allowed to pass into the gel, 4·9 mL of wash buffer was then added, and when this had passed into the column a further 5·0 mL wash buffer was added. The entire eluate, containing the non-glycosylated albumin, was collected and diluted 1 in 4 with distilled water. Glycosylated albumin was eluted with 4 mL sorbitol buffer (200 mrnol/L sorbitol, 50 mmol/L EDTA, 100 mmol/L Tris and 3 mrnol/L sodium azide, pH adjusted to . The entire chromatographic procedure was performed at room temperature (2Q-25°C).
A rocket immunoelectrophoresis plate was prepared by adding 5 ul. anti-human albumin (Seward Laboratories, London, UK) to 20 mL molten (56°C) agarose (Miles laboratories Ltd, Slough, UK) and mixed by inversion. The gel was poured on to a 110 x 125 mm Gelbond plate (Miles Laboratories Ltd) and allowed to solidify. A row of 2·5 mm wells were cut 5 mm apart and 2 em from one edge of the plate. Five microtitre samples of the fractions were placed in the walls, and electrophoresis performed at 80 V overnight using a pH 8·6 barbitone buffer.P The plates were dried and the resulting 'rockets' stained using coomassie blue.P their height measured and the concentration of each fraction calculated by comparison with standards (1-15 mgIL) (Hoechst UK Ltd, Hounslow, Middlesex, UK) run on the same plate. The albumin standards produced a straight line with a small positive intercept on the y-axis.
The percentage glycosylated albumin was calculated by:
[N-Albumin] = albumin concentration in nonglycosylated fraction.
Glycosylated haemoglobin was measured by affinity chromatography as previously described. 14 
REGENERATION OF THE GEL
After use, the affinity columns were regenerated with 5 mL water followed by 5 mL 0·1 M acetic acid, in which the columns were stored at 4°C. Before use the pH of the columns was restored by adding 5 mL wash buffer. During chromatography and storage columns were kept in the dark to avoid deterioration of the gel.
Results
EFFECT OF ALBUMIN CONCENTRATION
Loading increasing concentrations of albumin on to the column had the effect of artificially lowering the percentage glycosylated albumin result. Loading 100 ul, of sample containing 3 mg of albumin produced a low result when compared with 100 ul, samples of lower albumin concentrations (P<D·D5). This difference became greater with increasing albumin concentration loaded, presumably because of the increasing inclusion of glycosylated albumin in the first eluate, due to the overloading of the column. Recovery of albumin from the column was greater than 96% for all albumin concentrations loaded.
PERCENTAGE GLYCOSYLATED ALBUMIN IN
NON-DIABETIC AND DIABETIC SUBJECTS
Glycosylated albumin was estimated in 100 healthy hospital workers and in 100 insulindependent diabetics. The diabetic group produced significantly higher results (P<D·001) than the non-diabetic group ( Table 1 ). The observed range was wider in the diabetic group (6·1-22,3%) than in the non-diabetic group (1·9-5·8%). Unlike glycosylated haemoglobin, Different serum samples were used for assessing within-and between-batch precision.
the glycosylated albumin results in the nondiabetic group displayed a Gaussian distribution and produced a reference range for glycosylated albumin of 2·0-5·4%. PRECISION Samples collected from a diabetic subject and a non-diabetic subject were analysed for glycosylated albumin. The within-batch and betweenbatch precisions obtained are shown in Table 2 . Affinity chromatography 81 CORRELATION BETWEEN GLYCOSYLATED ALBUMIN AND GLYCOSYLATED HAEMOGLOBIN Glycosylated albumin and glycosylated haemoglobin were both measured by affinity chromatography on 116 blood samples (30 from non-diabetic subjects). The results (Fig. 1) show good correlation (r=0·91), with a slope of 0·75. The regression line does not pass through the origin but intersects the y-axis at -1·7%.
Glycosylated albumin showed poor correlation when compared with random blood glucose (r=0·33).
EFFECT OF HAEMOLYSIS
After preparation of diluted plasma, red cells from the same specimens were added to produce haemoglobin concentrations ranging from oto 4 gIL. These specimens were then analysed by the affinity method. The results indicated that haemoglobin concentrations in the diluted specimen of up to 3 g/L did not affect glycosylated albumin analysis.
REGENERATION OF THE GEL
Specimens from a diabetic subject and a non- diabetic subject were analysed on columns that had been regenerated 0, 2, 6, 8 and 10 times. On these columns, the above specimens produced results of 4·4, 4·0, 4·0, 4·0, and 3·8% (non-diabetic), and 8,7, 9·1, 8,7,9·1 and 9·1% (diabetic) respectively.
EFFECT OF ANTICOAGULANT
Ten blood samples were collected into fluoride oxalate anticoagulant tubes, and into tubes without anticoagulant. No significant difference was found for glycosylated albumin in the plasma and serum specimens.
Discussion
Separation of glycosylated albumin by affinity chromatography is a precise (3--{j% CV) and inexpensive procedure as columns can be regenerated 10 times. The non-glycosylated albumin elutes off the column in a single fraction, with no further elution of albumin until sorbitol buffer is added to elute the glycosylated fraction. Two distinct fractions can be collected and analysed for albumin concentration by rocket immunoelectrophoresis.
In the subjects studied no overlap was found between the observed ranges of glycosylated albumin from the diabetic and non-diabetic groups. The non-diabetic reference range for glycosylated albumin was found to be 2·0-5·4 %; this was significantly lower than the range of 5·0-8·5% we previously reported for glycosylated haemoglobin. 14 Shin et al. 16 used a thiobarbituric acid procedure to estimate the amount of glycosylation in washed red cells and in purified human albumin, and reported a similar difference in the ranges for these two proteins. In this present study the finding that in the non-diabetic range albumin is glycosylated to a lesser extent than haemoglobin may be expected due to the shorter half-life of albumin.
Recently a kit (Glycogel Test Kit, Pierce and Warriner) has become available for the analysis of glycosylated albumin and glycosylated plasma proteins. This method requires the loading of 200 ul, undiluted plasma on to the affinity column, and measuring albumin concentration in the fractions by BCG. We found that when more than 3 mg of albumin was loaded on to a 1 mL affinity column, apparently low percentage glycosylated albumin results were obtained. This was possibly due to the saturation of binding sites on the column, as the recovery of albumin from the column was similar for all albumin concentrations loaded. This finding is similar to that described by Gould et at." The volume of serum (200 ilL) the manufacturers recommend for loading on to the column contains 8-10 mg albumin. Adding this amount of albumin has the effect of overloading the column; to avoid this the total albumin added to a 1 mL column should not exceed 3 mg.
Plasma contains a mixture of different proteins, with differing half-lives, and therefore measurement of glycosylated plasma proteins may be difficult to interpret. The half-life of albumin is known, and measurement of glycosylated albumin may, therefore, provide a more useful indicator of glycaemic control over a specific time period. A good correlation is shown between glycosylated albumin and glycosylated haemoglobin. This can be expected as the process of non-enzymic glycosylation has been shown to be a similar process in these two proteins." The negative intercept found when these two proteins were correlated, may be due to their different turnover rates. The finding that albumin is proportionally glycosylated to a greater extent than haemoglobin in the diabetic range," may also have contributed to this negative intercept. Kennedy and Merimee" suggested that a change in average blood glucose concentration will not be detectable by glycosylated haemoglobin for about 7-8 weeks, whereas glycosylated albumin with a much shorter life (20-30 days) will reflect this change in 1-2 weeks.
Affinity chromatography provides a reliable method for the measurement of glycosylated albumin, which is not affected by haemolysis. Collection of blood into fluoride oxalate permits the measurement of glycosylated albumin, glycosylated haemoglobin and blood glucose on the same specimen. The measurement of all three parameters on the same sample may provide a useful profile of glycaemic control.
